Key facts
- AmphiStar’s last known valuation is $15.2M (Apr 2024).
- It has raised $21.8M; the latest was Seed Round ($14.5M) in Jul 2025.
- Notable investors include European Innovation Council, Participatiemaatschappij Vlaanderen, ECBF Management, ECBF, European Innovation Council (Belgium) — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for AmphiStar
- ·The full record, as it builds
Funding rounds
No funding rounds for AmphiStar are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AmphiStar
Developer of a biosurfactant technology platform designed to aid the transition from a fossil-based to a more environmentally friendly and bio-based industry. The company's production processes are based on industrial biotechnology and use sustainable, renewable raw materials such as biomass feedstocks like glucose and fatty acids, crude glycerine and food waste, enabling the healthcare industry to maintain sustainability in the production of biosurfactants.
- Sector
- Materials and Resources
- HQ
- Ghent, Belgium
- Founded
- 2021
- Employees
- 21
- Website
- amphistar.com/
- Ownership
- Privately Held (backing)
AmphiStar doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AmphiStar shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AmphiStar in its N-PORT filings yet. We sweep new filings monthly.